• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤维蛋白溶解剂:治疗成人呼吸窘迫综合征的新方法。

Fibrinolytic agents: a new approach to the treatment of adult respiratory distress syndrome.

作者信息

Hardaway R M, Harke H, Williams C H

机构信息

Texas Tech University School of Medicine, El Paso.

出版信息

Adv Ther. 1994 Mar-Apr;11(2):43-51.

PMID:10147145
Abstract

Nineteen patients suffering from adult respiratory distress syndrome (ARDS) secondary to trauma or sepsis, or both, failed to respond to treatment with mechanical ventilation with oxygen and positive end-expiratory pressure. On the premise that ARDS may be caused by the microclots of disseminated intravascular coagulation obstructing the pulmonary microcirculation, the patients were treated with either streptokinase or urokinase. Eighteen patients responded with significant improvement in PaO 2 value. No bleeding occurred and clotting parameters remained normal.

摘要

19名因创伤或脓毒症继发成人呼吸窘迫综合征(ARDS),或两者皆有的患者,对氧气和呼气末正压通气治疗无反应。基于ARDS可能由弥散性血管内凝血的微血栓阻塞肺微循环引起这一前提,这些患者接受了链激酶或尿激酶治疗。18名患者的动脉血氧分压(PaO₂)值显著改善。未发生出血,凝血参数保持正常。

相似文献

1
Fibrinolytic agents: a new approach to the treatment of adult respiratory distress syndrome.纤维蛋白溶解剂:治疗成人呼吸窘迫综合征的新方法。
Adv Ther. 1994 Mar-Apr;11(2):43-51.
2
Treatment of severe acute respiratory distress syndrome: a final report on a phase I study.严重急性呼吸窘迫综合征的治疗:一项I期研究的最终报告。
Am Surg. 2001 Apr;67(4):377-82.
3
Effects of sustained inflation and postinflation positive end-expiratory pressure in acute respiratory distress syndrome: focusing on pulmonary and extrapulmonary forms.持续充气及充气后呼气末正压对急性呼吸窘迫综合征的影响:聚焦肺型和肺外型
Crit Care Med. 2003 Mar;31(3):738-44. doi: 10.1097/01.CCM.0000053554.76355.72.
4
Changes in the fibrinolysin system in infantile and adult respiratory distress syndrome (ARDS), caused by trauma and/or septic shock in patients and in experimental animals.由患者和实验动物的创伤和/或脓毒性休克引起的婴儿和成人呼吸窘迫综合征(ARDS)中纤维蛋白溶解系统的变化。
J Med. 1990;21(1-2):67-84.
5
Acute respiratory distress syndrome after liver transplantation: etiology, prevention and management.
Hepatobiliary Pancreat Dis Int. 2002 Aug;1(3):330-4.
6
Pressure control inverse ratio ventilation in the treatment of adult respiratory distress syndrome in patients with blunt chest trauma.压力控制反比通气在钝性胸部创伤患者成人呼吸窘迫综合征治疗中的应用
Am Surg. 1999 Nov;65(11):1027-30.
7
Extended prone position ventilation in severe acute respiratory distress syndrome: a pilot feasibility study.严重急性呼吸窘迫综合征中的延长俯卧位通气:一项初步可行性研究。
J Crit Care. 2009 Mar;24(1):81-8. doi: 10.1016/j.jcrc.2008.02.005. Epub 2008 May 14.
8
[Intensive care of acute respiratory distress syndrome in septic shock--a case report (author's transl)].脓毒性休克中急性呼吸窘迫综合征的重症监护——病例报告(作者译)
Wien Klin Wochenschr. 1980 Apr 25;92(9):321-6.
9
[Evaluation of glucocorticoid in treatment for patients with acute respiratory distress syndrome as a result of serious community-acquired pneumonia].[糖皮质激素用于治疗重症社区获得性肺炎所致急性呼吸窘迫综合征患者的疗效评估]
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2003 Nov;15(11):669-74.
10
Extrapulmonary ventilation for unresponsive severe acute respiratory distress syndrome after pulmonary resection.肺切除术后无反应性重症急性呼吸窘迫综合征的肺外通气
Ann Thorac Surg. 2008 Jan;85(1):237-44; discussion 244. doi: 10.1016/j.athoracsur.2007.06.004.

引用本文的文献

1
Pharmacotherapy consideration of thrombolytic medications in COVID-19-associated ARDS.新型冠状病毒肺炎相关急性呼吸窘迫综合征中溶栓药物的药物治疗考量
J Intensive Care. 2022 Jul 30;10(1):38. doi: 10.1186/s40560-022-00625-4.
2
Fibrinolytic therapy for refractory COVID-19 acute respiratory distress syndrome: Scientific rationale and review.用于难治性新型冠状病毒肺炎急性呼吸窘迫综合征的纤溶治疗:科学原理与综述
Res Pract Thromb Haemost. 2020 Jun 12;4(4):524-531. doi: 10.1002/rth2.12357. eCollection 2020 May.
3
Nebulization of Single-Chain Tissue-Type and Single-Chain Urokinase Plasminogen Activator for Treatment of Inhalational Smoke-Induced Acute Lung Injury.
雾化单链组织型和单链尿激酶型纤溶酶原激活剂治疗吸入烟雾所致急性肺损伤
J Drug Deliv Sci Technol. 2018 Aug;48:19-27. doi: 10.1016/j.jddst.2018.04.013. Epub 2018 Apr 30.
4
Anticoagulant therapy in acute respiratory distress syndrome.急性呼吸窘迫综合征中的抗凝治疗。
Ann Transl Med. 2018 Jan;6(2):36. doi: 10.21037/atm.2018.01.08.
5
Targeting of plasminogen activator inhibitor 1 improves fibrinolytic therapy for tetracycline-induced pleural injury in rabbits.靶向纤溶酶原激活物抑制剂1可改善四环素诱导的兔胸膜损伤的纤溶治疗。
Am J Respir Cell Mol Biol. 2015 Apr;52(4):429-37. doi: 10.1165/rcmb.2014-0168OC.
6
Active α-macroglobulin is a reservoir for urokinase after fibrinolytic therapy in rabbits with tetracycline-induced pleural injury and in human pleural fluids.在四环素诱导的兔胸膜损伤和人胸腔液中,活性α-巨球蛋白是纤维蛋白溶解治疗后尿激酶的储库。
Am J Physiol Lung Cell Mol Physiol. 2013 Nov 15;305(10):L682-92. doi: 10.1152/ajplung.00102.2013. Epub 2013 Aug 30.
7
Novel aspects of urokinase function in the injured lung: role of α2-macroglobulin.尿激酶功能在受损肺部的新方面:α2-巨球蛋白的作用。
Am J Physiol Lung Cell Mol Physiol. 2012 Dec 15;303(12):L1037-45. doi: 10.1152/ajplung.00117.2012. Epub 2012 Oct 12.
8
Effects of extracellular DNA on plasminogen activation and fibrinolysis.细胞外 DNA 对纤溶酶原激活和纤维蛋白溶解的影响。
J Biol Chem. 2011 Dec 9;286(49):41949-41962. doi: 10.1074/jbc.M111.301218. Epub 2011 Oct 5.
9
Wood bark smoke induces lung and pleural plasminogen activator inhibitor 1 and stabilizes its mRNA in porcine lung cells.木材燃烧烟雾诱导猪肺细胞中肺和胸膜纤溶酶原激活物抑制剂 1 的产生并稳定其 mRNA。
Shock. 2011 Aug;36(2):128-37. doi: 10.1097/SHK.0b013e31821d60a4.
10
Emerging role of anticoagulants and fibrinolytics in the treatment of acute respiratory distress syndrome.抗凝剂和纤溶剂在急性呼吸窘迫综合征治疗中的新作用
Pharmacotherapy. 2007 Jun;27(6):860-73. doi: 10.1592/phco.27.6.860.